Delivery Order SPE2DB20D1004-SPE2DB21FE9F5
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $23,195.30 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, syringes, vials, and other critical care materials. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $5,079.35 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of various pharmaceutical and medical products, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical devices, to support military treatment facilities and veterans' healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $34,500.00 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for pharmaceutical and medical supplies. This Delivery Order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $21,296.35, is for the delivery of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,427.93 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of pharmaceutical products and medical supplies. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of medications, devices, and...
- The U.S. government agency Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $3,871.17 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and vaccines. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $13,194.33 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for pharmaceutical and medical supplies. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which runs through November 2026. The contract covers a broad range of essential medical commodities, including specialty...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $427,275.13 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This contract is for the supply of pharmaceutical products and medical supplies to support military treatment facilities and healthcare programs. The contract has no set-aside designation and is a Firm Fixed Price Delivery Order. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has extensive experience in...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,670.05 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract covers the provision of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to...
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a delivery order contract valued at $6,129.59 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which runs through December 2025. The contract is for the delivery of a wide range of pharmaceutical products and medical supplies, including...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FE9F5Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $18,288.65 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the provision of a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.3k | 12/7/20 |